BEAM Chemotherapy: Combination Chemotherapy Regimens

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the context of Hodgkin's lymphoma that includes dexa-BEAM and mini-BEAM. They are also used as salvage or preparative regimens, some prior to stem cell transplantations.

BEAM Chemotherapy Drugs

The drugs that are in the standard BEAM chemotherapy are:

BCNU (carmustine)
Etoposide
Ara-C (cytarabine)
Melphalan

BEAM chemotherapy is an intense, high-dose six-day regimen that normally unrolls like this:

BEAM Chemotherapy Doses

Day 1: Carmustine (intravenous)
Days 2, 3, 4, 5: Etoposide (intravenous infusion); Cytarabine (intravenous infusion)
Day 6: Melphalan (intravenous)
Day 7: The patient undergoes the scheduled autologous stem cell transplantation

[Technically, the days should be numbered as a countdown; i.e. day 1= day -6, day 2=day -5 and so on until day 7, which equals day 0. I have done the opposite for easier understanding].

Dexa-BEAM Chemotherapy

Dexa-BEAM is an intense salvage chemotherapy regimen. The drugs used are as follows:

Dexamethasone
BCNU (carmustine)
Etoposide
Ara-C (cytarabine)
Melphalan

Dexa-BEAM chemotherapy unfolds as follows:

Cycle length: 28 days
Number of cycles: 2-4
Days 1-10: Dexamethasone (oral)
Day 2: BCNU (carmustine)
Day 3: Melphalan
Days 4-7: Etoposide (IV) & cytarabine (IV)

Mini-BEAM Chemotherapy

Mini-BEAM chemotherapy is a less dose-intense regimen that can be used as salvage chemotherapy or as a preparative regimen for a stem cell transplantation.

Cycle length: 28 days
Number of cycles: 2-4
Day 1: Carmustine
Days 2-5: Etoposide (IV); cytarabine (IV)
Day 6: Melphalan (IV)

If this regimen is used as a preparative regimen for a stem cell transplantation, the transplant would occur on the seventh day.

Sources

Boyiadzis, Michael M. et al. Hematology-Oncology Therapy. New York: McGraw Hill, Medical Publishing Division.

Perry, Michael C, Editor. Companion Handbook to the Chemotherapy Sourcebook. Baltimore; Williams & Wilkins.

Photo: Pexels

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...